STAT3 and neoplasm: On the basis of these results, it could be conceivable to hypothesize STAT3 as a new valid cellular target to develop therapeutic strategies based on the inhibition of STAT3-mediated pathways, in addition to conventional chemotherapy, to deal with tumours in patients exposed to POPs (i.e., β-HCH).